Quality of Life in elderly patients with cancer

by Perrone Francesco, Di Maio Massimo
Published 2003-09-01

Quality of Life in elderly patients with cancer

by Di Maio, Massimo, Perrone, Francesco
Published 2003

A review of guidelines for lung cancer

by Bironzo, Paolo, Di Maio, Massimo
Published in J Thorac Dis (2018)

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

by Metro, Giulio, Di Maio, Massimo
Published in Transl Lung Cancer Res (2018)

Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

by Metro, Giulio, Di Maio, Massimo
Published in Transl Lung Cancer Res (2018)

The lesson learned from figitumumab clinical program and the hope for better results in squamous lung cancer

by Di Maio, Massimo, Scagliotti, Giorgio Vittorio
Published in Transl Lung Cancer Res (2015)

Real‐World Evidence in Oncology: Opportunities and Limitations

by Di Maio, Massimo, Perrone, Francesco, Conte, Pierfranco
Published in Oncologist (2019)

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

by Facchinetti, Francesco, Di Maio, Massimo, Tiseo, Marcello
Published in Cancers (Basel) (2020)

Raising the bar for enthusiasm when looking at results of randomized phase II trials—the case of sunitinib in small-cell lung cancer

by Di Maio, Massimo, Bironzo, Paolo, Scagliotti, Giorgio Vittorio
Published in Transl Lung Cancer Res (2016)

Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence

by De Luca, Emmanuele, Marino, Donatella, Di Maio, Massimo
Published in Cancer Manag Res (2020)

The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer

by Reale, Maria Lucia, De Luca, Emmanuele, Di Maio, Massimo
Published in Transl Lung Cancer Res (2020)

COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice

by Marandino, Laura, Necchi, Andrea, Aglietta, Massimo, Di Maio, Massimo
Published in JCO Oncol Pract (2020)

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis

by Facchinetti, Francesco, Di Maio, Massimo, Perrone, Fabiana, Tiseo, Marcello
Published in Transl Lung Cancer Res (2021)

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-...

by Addeo, Alfredo, Banna, Giuseppe Luigi, Metro, Giulio, Di Maio, Massimo
Published in Front Oncol (2019)

Second-line treatment options in hepatocellular carcinoma

by Marino, Donatella, Zichi, Clizia, Audisio, Marco, Sperti, Elisa, Di Maio, Massimo
Published in Drugs Context (2019)

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

by Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Published in Transl Lung Cancer Res (2021)

BRAF-mutated metastatic colorectal cancer between past and future

by Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Published in Br J Cancer (2015)

Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic

by Fratino, Lucia, Procopio, Giuseppe, Di Maio, Massimo, Cinieri, Saverio, Leo, Silvana, Beretta, Giordano
Published in Front Oncol (2020)

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

by Tucci, Marcello, Zichi, Clizia, Buttigliero, Consuelo, Vignani, Francesca, Scagliotti, Giorgio V, Di Maio, Massimo
Published in Onco Targets Ther (2018)

The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey

by Marandino, Laura, Di Maio, Massimo, Procopio, Giuseppe, Cinieri, Saverio, Beretta, Giordano Domenico, Necchi, Andrea
Published in Eur Urol (2020)